NCT02642718View on ClinicalTrials.gov

Pre-operative Ketorolac Administration Has no Pre-emptive Analgesic Effect Following Total Abdominal Hysterectomy

PHASE4CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

April 30, 2001

Primary Completion Date

October 31, 2001

Study Completion Date

November 30, 2001

Conditions
Pain
Interventions
DRUG

Ketorolac Tromethamine

In the operating room, the anesthesiologist administered ketorolac (30 mg) in 50 mL of 0.9 % saline intravenously to patients in the ketorolac group 30 minutes before surgical incision (a single dose).

OTHER

Placebo

In the operating room, the anesthesiologist administered 50 mL of 0.9 % saline intravenously to patients in the control group 30 minutes before surgical incision

Trial Locations (2)

15405

Complexo Hospitalario Arquitecto Marcide-Prof. Novoa Santos, Ferrol

OX3 9DU

Oxford University Hospitals NHS Trust, Oxford

All Listed Sponsors
lead

Hospital Arquitecto Marcide

OTHER

NCT02642718 - Pre-operative Ketorolac Administration Has no Pre-emptive Analgesic Effect Following Total Abdominal Hysterectomy | Biotech Hunter | Biotech Hunter